Termination of Licenses. Except as necessary for Oragenics to continue to obtain regulatory approval for, clinically develop, use, manufacture and Commercialize the Retained Products in the Field as permitted by Section 10.4(a), all rights and licenses granted by Intrexon to Oragenics under this Agreement shall terminate and shall revert to Intrexon without further action by either Intrexon or Oragenics. Oragenics’ license with respect to Retained Products shall be exclusive or non-exclusive, as the case may be, on the same terms as set forth in Section 3.1.
Appears in 5 contracts
Samples: Exclusive Channel Collaboration Agreement (Oragenics Inc), Exclusive Channel Collaboration Agreement (Oragenics Inc), Exclusive Channel Collaboration Agreement (Intrexon Corp)
Termination of Licenses. Except as necessary for Oragenics to continue to obtain regulatory approval for, clinically develop, use, manufacture and Commercialize the Retained Products in the Field as permitted by Section 10.4(a), all rights and licenses granted by Intrexon EGI to Oragenics under this Agreement shall terminate and shall revert to Intrexon EGI without further action by either Intrexon EGI or Oragenics. Oragenics’ license with respect to Retained Products shall be exclusive or non-exclusive, as the case may be, on the same terms as set forth in Section 3.1.
Appears in 1 contract
Samples: Exclusive Channel Collaboration Agreement (Oragenics Inc)